Infant Clinical Trial
— MJAUOfficial title:
Iron Absorption From Iron-fortified Infant Formula and Iron Drops in Infants (MJAU-studien)
Verified date | March 2020 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Iron deficiency (ID) affects up to 25% of Swedish infants and severe ID is associated with cognitive and behavioral problems. To avoid this, iron supplements or iron-fortified infant foods are recommended for infants. However, the optimal iron dose and mode of delivery have not yet been established. This is a concern as excessive iron intake may impair growth and increase morbidity in iron-sufficient infants. Previous studies have suggested that iron-fortified foods may have different effects than iron supplements. In this study, the investigators will investigate whether the mode of iron administration (supplementation vs. fortification) and the amount consumed (high intakes vs. low intakes) affect iron absorption, iron utilization, and zinc absorption in healthy term non-iron-deficient 6-month-old infants.
Status | Completed |
Enrollment | 72 |
Est. completion date | June 2012 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Months to 7 Months |
Eligibility |
Inclusion Criteria: - 6-7 months of age at the start of intervention - healthy at enrollment - full-term (>37 gestational weeks at birth) - birth weight >2500 g - predominantly bottle-fed at recruitment Exclusion Criteria: - iron deficiency at enrollment - previous or current use of iron supplements |
Country | Name | City | State |
---|---|---|---|
Sweden | Department of Clinical Sciences, Pediatrics, Umeå University Hospital | Umeå |
Lead Sponsor | Collaborator |
---|---|
Umeå University | Swiss Federal Institute of Technology, University of California, Davis |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | iron absorption | 1 month after enrollment | ||
Secondary | indicators of iron metabolism, growth, and oxidative stress | 1 month and 1.5 months after enrollment | ||
Secondary | zinc absorption | 1 month after enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01162798 -
Preterm Infant Growth
|
N/A | |
Completed |
NCT00808756 -
Study on Fermentable Carbohydrates in Healthy Infants
|
N/A | |
Completed |
NCT00355654 -
Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®
|
Phase 3 | |
Recruiting |
NCT06032494 -
Investigating Changes in Vital Signs in Neonates
|
||
Not yet recruiting |
NCT05914324 -
Outpatient Pediatric Pulse Oximeters in Africa
|
N/A | |
Completed |
NCT04523441 -
Early Support and Physiotherapy for Children and Their Motor Skills
|
||
Completed |
NCT02441296 -
Carbohydrate and Metabolism: a Pilot Study
|
N/A | |
Completed |
NCT00507676 -
Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing
|
N/A | |
Recruiting |
NCT05072626 -
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
|
||
Completed |
NCT04536194 -
Dopamine Versus Norepinephrine Under General Anesthesia
|
Phase 3 | |
Recruiting |
NCT04598061 -
IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
|
||
Completed |
NCT03567031 -
Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia
|
N/A | |
Completed |
NCT02366780 -
Breast Milk Content Expressed Manually Compared to Electric Pump
|
N/A | |
Terminated |
NCT04641000 -
The Alberta BLOOM Long Term Follow Up Study
|
||
Completed |
NCT02580123 -
Smile-Kids: Study on Complementary Feeding Transition
|
N/A | |
Completed |
NCT00294294 -
Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa
|
Phase 4 | |
Recruiting |
NCT04967118 -
Neonatal Pain Management and Pain Monitoring Using New Methods
|
N/A | |
Completed |
NCT03025178 -
Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants
|
N/A | |
Completed |
NCT02722759 -
Haemoglobin Measurement for Babies
|
N/A | |
Recruiting |
NCT01147601 -
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
|
Phase 0 |